Screening for atrial fibrillation (AF) using digital technology in smartphones provides benefits in detection and treatment rates in older patients compared with routine screening, according to late-breaking findings from the European Society of Cardiology Congress 2022. The eBRAVE-AF study met its primary endpoint, suggesting that digital screening more than doubled the detection rate of treatment-relevant AF in each trial phase. Source: MDMag To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more